“In-Silico Drug Design And Adme Studies Of Substituted 1, 3, 4-Oxadiazole Analogues As Potent Mycobacterial Dpre1 Enzyme Inhibitors”, Journal of Pharmaceutical Negative Results, pp. 2793–2803, Feb. 2023, doi: 10.47750/pnr.2023.14.S02.329.